YUNNAN BAIYAO GROUP CO.,LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.33 CNY | -0.23% |
|
-1.20% | +12.57% |
| Apr. 01 | Yunnan Baiyao Group Co.,Ltd Proposes Final Cash Dividend for 2023 | CI |
| Apr. 01 | Yunnan Baiyao Group's Profit Rises 30% as Operating Income Increases | MT |
| Sales 2024 * | 42.27B 5.83B | Sales 2025 * | 45.85B 6.33B | Capitalization | 98.72B 13.62B |
|---|---|---|---|---|---|
| Net income 2024 * | 4.59B 634M | Net income 2025 * | 5.07B 700M | EV / Sales 2024 * | 2 x |
| Net cash position 2024 * | 14.15B 1.95B | Net cash position 2025 * | 16.23B 2.24B | EV / Sales 2025 * | 1.8 x |
| P/E ratio 2024 * |
21.6
x | P/E ratio 2025 * |
19.6
x | Employees | 8,834 |
| Yield 2024 * |
3.96% | Yield 2025 * |
3.92% | Free-Float | 38.26% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.23% | ||
| 1 week | -1.20% | ||
| Current month | +8.92% | ||
| 1 month | +8.68% | ||
| 3 months | +12.73% | ||
| 6 months | +12.19% | ||
| Current year | +12.57% |
1 week
54.80
57.61
1 month
49.7857.61
Current year
44.8857.61
1 year
44.8859.90
3 years
44.8893.63
5 years
44.88116.63
10 years
33.64116.63
| Managers | Title | Age | Since |
|---|---|---|---|
Ming Dong
CEO | Chief Executive Officer | 47 | 21-03-02 |
Jia Ma
DFI | Director of Finance/CFO | 47 | 22-05-31 |
Pin Yao Yin
COO | Chief Operating Officer | 55 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yun Shan Xie
BRD | Director/Board Member | 49 | 22-11-06 |
Ying Xia He
BRD | Director/Board Member | 52 | 89-11-30 |
Guo En Liu
BRD | Director/Board Member | 67 | 21-05-24 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.68% | 2 M€ | -18.13% | - | |
| 1.32% | 2 M€ | -14.14% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 55.33 | -0.23% | 7,938,530 |
| 24-04-24 | 55.46 | -0.82% | 10,709,100 |
| 24-04-23 | 55.92 | -0.90% | 11,456,260 |
| 24-04-22 | 56.43 | -0.49% | 13,703,900 |
| 24-04-19 | 56.71 | +1.27% | 15,000,310 |
End-of-day quote Shenzhen S.E., April 24, 2024
More quotes
Yunnan Baiyao Group Co., Ltd. specializes in the development, manufacturing and marketing of pharmaceutical products. The group proposes primarily traditional medicine products, phytobiological products, body care products, antibiotics and anti-inflammatory.
China accounts for 98.9% of net sales.
Sector
Pharmaceuticals
Calendar
2024-04-26
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
55.33
CNY
Average target price
62.1
CNY
Spread / Average Target
+12.24%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +12.57% | 13.66B | |
| +24.17% | 562B | |
| -6.33% | 358B | |
| +19.90% | 322B | |
| +7.95% | 297B | |
| +13.45% | 219B | |
| +6.04% | 199B | |
| -10.51% | 196B | |
| -12.26% | 149B | |
| -6.47% | 146B |
- Stock Market
- Equities
- 000538 Stock
